Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.44 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 2/20 | 0.35 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.32 |
| ▸ | PTPRF | P10586 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25834646 | 1.00 | CRHBP (0.44) | CRHBPCRHR2MAOAMAOBBACE1 | |
| SCHEMBL25834334 | 0.83 | CRHBP (0.57) | CRHBPCRHR2MAOAMAOBBACE1 | |
| SCHEMBL25834647 | 0.79 | MAOA (0.38) | CRHBPCRHR2MAOAMAOBBACE1 | |
| SCHEMBL25834335 | 0.69 | CRHBP (0.42) | CRHBPCRHR2MAOAMAOBBACE1 | |
| SCHEMBL25834638 | 0.68 | ALDH1A1 (0.45) | CRHBPCRHR2BACE1CYP1A2 | |
| SCHEMBL25834336 | 0.67 | SLC6A2 (0.34) | CRHBPCRHR2MAOAMAOBCYP1A2 | |
| SCHEMBL25835234 | 0.67 | ALDH1A1 (0.32) | CRHBPCRHR2 | |
| SCHEMBL25834648 | 0.67 | ALDH1A1 (0.32) | CRHBPCRHR2 | |
| SCHEMBL25835232 | 0.66 | MAOA (0.38) | CRHBPCRHR2MAOAMAOBBACE1 | |
| SCHEMBL25834603 | 0.65 | BACE1 (0.42) | MAOAMAOBBACE1HSD17B3PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227393-A1 | IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES | THE UNIVERSITY OF HONG KONG (CN) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227393-A1 | IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES | NFE2L2, DUOX1, DUOX2 | CRHBP 3490/4885CRHR2 2001/4885MAOA 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.